Keeren Shah
Direttore Finanziario/CFO presso ACTAVIA LIFE SCIENCES, INC.
Patrimonio netto: 118 $ in data 31/05/2024
Profilo
Keeren Shah is currently working as a Member at The Chartered Institute of Management Accountants.
Additionally, Ms. Shah holds the position of Chief Financial Officer at OKYO Pharma Ltd., Actavia Life Sciences, Inc., AccuStem Sciences, Inc., and Tiziana Life Sciences Ltd.
In the past, Ms. Shah worked as a Finance Director at Rasna Therapeutics, Inc.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
ACCUSTEM SCIENCES INC
0.00% | 31/12/2023 | 250 ( 0.00% ) | 118 $ | 31/05/2024 |
Posizioni attive di Keeren Shah
| Società | Posizione | Inizio |
|---|---|---|
| ACTAVIA LIFE SCIENCES, INC. | Direttore Finanziario/CFO | 31/07/2020 |
| OKYO PHARMA LIMITED | Direttore Finanziario/CFO | 01/08/2020 |
| ACCUSTEM SCIENCES, INC. | Direttore Finanziario/CFO | 01/08/2021 |
| TIZIANA LIFE SCIENCES LTD | Direttore Finanziario/CFO | - |
The Chartered Institute of Management Accountants
 The Chartered Institute of Management Accountants Other Consumer ServicesConsumer Services The Chartered Institute of Management Accountants, also known as aicpa® & cima®, is a global organization with 689,000 members, students, and professionals. The non-profit company is based in London, UK, and has a global presence of subsidiaries in several regions. The British company advocates for the accounting and finance profession, as well as the public interest and business sustainability. Andrew Harding has been the CEO of the company since 2009. | Corporate Officer/Principal | - |
Precedenti posizioni note di Keeren Shah
| Società | Posizione | Fine |
|---|---|---|
Rasna Therapeutics, Inc. /Old/
 Rasna Therapeutics, Inc. /Old/ Medical DistributorsDistribution Services Rasna Therapeutics, Inc. operates as a development stage biotechnology company focused on the development of cancer drugs. It is focused primarily on the development of drug candidates for leukemia and lymphoma. The company was founded by Gabriele Marco Antonio Cerrone, Roberto Pellicciari and Brunangelo Falini in 2013 and is headquartered in San Diego, CA. | Direttore Finanziario/CFO | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 4 |
|---|---|
| ACTAVIA LIFE SCIENCES, INC. | Health Technology |
| OKYO PHARMA LIMITED | Health Technology |
| ACCUSTEM SCIENCES, INC. | Health Technology |
| TIZIANA LIFE SCIENCES LTD | Health Technology |
| Aziende private | 2 |
|---|---|
The Chartered Institute of Management Accountants
The Chartered Institute of Management Accountants Other Consumer ServicesConsumer Services The Chartered Institute of Management Accountants, also known as aicpa® & cima®, is a global organization with 689,000 members, students, and professionals. The non-profit company is based in London, UK, and has a global presence of subsidiaries in several regions. The British company advocates for the accounting and finance profession, as well as the public interest and business sustainability. Andrew Harding has been the CEO of the company since 2009. | Consumer Services |
Rasna Therapeutics, Inc. /Old/
Rasna Therapeutics, Inc. /Old/ Medical DistributorsDistribution Services Rasna Therapeutics, Inc. operates as a development stage biotechnology company focused on the development of cancer drugs. It is focused primarily on the development of drug candidates for leukemia and lymphoma. The company was founded by Gabriele Marco Antonio Cerrone, Roberto Pellicciari and Brunangelo Falini in 2013 and is headquartered in San Diego, CA. | Distribution Services |
- Borsa valori
- Insiders
- Keeren Shah
